Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GI Tolerability of Bafiertam vs Tecfidera in Healthy Volunteers
NCT04022473Phase 1Completed
- Sponsor
- Banner Life Sciences
- Start
- Jul 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of monomethyl fumarate in multiple sclerosis (MS) (2 arms), sponsored by Banner Life Sciences. Primary endpoint: Area Under the Curve (AUC) in each of the individual symptoms over the treatment period at 5 weeks. Started Jul 2019; status: completed.
02
Drugs
monomethyl fumarate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT04022473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04022473.